- ￥1168 - 1868
- abinScience
- France
- ZP005025
- 2026年09月03日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Anti-Hydra vulgaris Transcription Factor Sp5-like Monoclonal Antibody (1A131)
- 供应商：
武汉研升生物科技有限公司
- 规格：
50μg/100μg
| 规格： | 50μg | 产品价格： | ￥1168.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥1868.0 |
| 产品名称 | Anti-Hydra vulgaris Transcription Factor Sp5-like Monoclonal Antibody (1A131) |
| 货号 | ZP005025 |
| 描述 | Anti-Hydra vulgaris Transcription Factor Sp5-like Monoclonal Antibody (1A131) [1A131] ( ZP005025 ) is a mouse monoclonal antibody detecting Transcription Factor Sp5-like in ELISA, IHC, WB . Suitable for Hydra vulgaris . Highlights Recombinant — Superior batch-to-batch reproducibility with defined sequences. Multi-Application — Validated across multiple applications. |
| 反应种属 | Hydra vulgaris |
| 应用实验 | ELISA, IHC, WB |
| 宿主/表达体系 | Mouse |
| 克隆类型 | Monoclonal |
| 靶点 | Transcription Factor Sp5-like |
| 状态 | Liquid |
| 储存温度 | -20℃ |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
Notes on Making Rat x Y3 Monoclonal Antibody Producing Hybridomas
are very stable - even in long term large scale cultures (bioreactors). b) High levels of monoclonal antibody secretion in culture - often 100 micrograms per ml of ordinary tissue culture, without recloning, and up to 5 milligrams per ml in hollow fibre
Generation of Poly(ADP-ribosyl)ation Deficient Mutants of the Transcription Factor, CTCF
to produce such mutants, demonstrated by the example of CTCF, a transcription factor. To achieve this in our study, the protein domain modified by PARylation was mapped and the amino acids, which can be potentially PARylated, selected. Mutations
技术资料暂无技术资料 索取技术资料
